🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT05285735
Recruiting Observational

Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants

NCT05285735 · tracked via the Priya Life Science USA tracker
Sponsor
Amivas Inc.
Phase
Observational
Started
2022-06-08
Last updated
2024-01-30

Condition(s) studied

PregnancyMalaria

Study summary

This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.

Eligibility

Sex
FEMALE
Min age
15 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: * Patient received IV Artesunate * Patient was pregnant while receiving IV Artesunate * Patient was at least 15 years of age * Patient or legal guardian/representative gave consent for the study and to collect data from her physicians Exclusion Criteria • None

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
4C Pharma Solutions Piscataway New Jersey Recruiting

More Amivas Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05285735 on ClinicalTrials.gov ↗ ← All trials in the USA